Global Amlodipine Besylater Market

Amlodipine Besylater Comprehensive Study by Type (2.5mg, 5mg, 10mg), Application (High Blood Pressure, Heart Disease), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Ingredients (Microcrystalline Cellulose, Dibasic Calcium Phosphate Anhydrous, Sodium Starch Glycolate, Others) Players and Region - Global Market Outlook to 2028

Amlodipine Besylater Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
What is Amlodipine Besylater Market?

Amlodipine is used to treat high blood pressure and also helps to prevent heart attacks, kidney problem, and strokes. Amlodipine Besylate is basically white crystalline powder which is soluble in water and sparingly soluble in ethanol. The molecular weight of Amlodipine besylate is 567.1. The increasing number of hypertensive patients across the world and rising old age population are likely to be a prime driver for the global amlodipine besylate market.

Highlights from Amlodipine Besylater Market Study
AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledPfizer Inc. (United States), Mylan N.V. (United States), Dr. Reddy's Laboratories (India), Apotex Inc. (Canada), Teva Pharmaceutical Industries Ltd. (Israel), Cipla Limited (India), Hikma Pharmaceuticals (United Kingdom), Strides Pharma Science Limited (India), Upsher-Smith Laboratories, LLC (United States) and Sun Pharmaceutical Industries Limited (India)


The global Amlodipine Besylate market is highly fragmented owing to the prevalence of small manufacturers over the giant players. Some of the key players in the market are Pfizer Inc. (United States), Mylan N.V. (United States), Dr. Reddy's Laboratories (India), among others Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Amlodipine Besylater market throughout the forecasted period.

Pfizer Inc. (United States), Mylan N.V. (United States), Dr. Reddy's Laboratories (India), Apotex Inc. (Canada), Teva Pharmaceutical Industries Ltd. (Israel), Cipla Limited (India), Hikma Pharmaceuticals (United Kingdom), Strides Pharma Science Limited (India), Upsher-Smith Laboratories, LLC (United States) and Sun Pharmaceutical Industries Limited (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aurobindo Pharma Limited (India), Lupin Pharmaceuticals (India), Zydus Pharmaceuticals (United States), Oxford PharmaGenesis Ltd. (United Kingdom), Wockhardt Ltd (India) and Epic Pharma, LLC (United States).

Amlodipine Besylater Market Segmentation:
ScopeSub-Segments
Application / End UserHigh Blood Pressure and Heart Disease
Type2.5mg, 5mg and 10mg
Distribution Channel Hospital Pharmacies,Retail Pharmacies,Online Pharmacies
IngredientsMicrocrystalline Cellulose,Dibasic Calcium Phosphate Anhydrous,Sodium Starch Glycolate,Others


On the basis of geography, the market of Amlodipine Besylater has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology Advancement in Amlodipine Besylate

Market Growth Drivers:
Change of lifestyle and Growing Aging of the Population and Increasing Number of Hypertensive Patients across the world

Challenges:
High Prices of Some Amlodipine Bisulfate Products

Restraints:
Issue related to Some Side Effect of Drugs

Opportunities:
Growing Demand from Emerging Market such as China, India, Brazil, among others

Key Target Audience
Manufacturers of Amlodipine Besylater, Suppliers of Amlodipine Besylater, Wholesalers, Distributors and Retailers of Amlodipine Besylater, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others

In 2015, Dr. Reddy’s Announces Company has Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets, which is available in 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, among others. Hence, this launched will increase the product portfolio of the company.


Report Objectives / Segmentation Covered

By Type
  • 2.5mg
  • 5mg
  • 10mg
By Application
  • High Blood Pressure
  • Heart Disease
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Ingredients
  • Microcrystalline Cellulose
  • Dibasic Calcium Phosphate Anhydrous
  • Sodium Starch Glycolate
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Change of lifestyle and Growing Aging of the Population
      • 3.2.2. Increasing Number of Hypertensive Patients across the world
    • 3.3. Market Challenges
      • 3.3.1. High Prices of Some Amlodipine Bisulfate Products
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Amlodipine Besylate
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Amlodipine Besylater, by Type, Application, Distribution Channel , Ingredients and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Amlodipine Besylater (Value)
      • 5.2.1. Global Amlodipine Besylater by: Type (Value)
        • 5.2.1.1. 2.5mg
        • 5.2.1.2. 5mg
        • 5.2.1.3. 10mg
      • 5.2.2. Global Amlodipine Besylater by: Application (Value)
        • 5.2.2.1. High Blood Pressure
        • 5.2.2.2. Heart Disease
      • 5.2.3. Global Amlodipine Besylater by: Ingredients (Value)
        • 5.2.3.1. Microcrystalline Cellulose
        • 5.2.3.2. Dibasic Calcium Phosphate Anhydrous
        • 5.2.3.3. Sodium Starch Glycolate
        • 5.2.3.4. Others
      • 5.2.4. Global Amlodipine Besylater Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Amlodipine Besylater (Volume)
      • 5.3.1. Global Amlodipine Besylater by: Type (Volume)
        • 5.3.1.1. 2.5mg
        • 5.3.1.2. 5mg
        • 5.3.1.3. 10mg
      • 5.3.2. Global Amlodipine Besylater by: Application (Volume)
        • 5.3.2.1. High Blood Pressure
        • 5.3.2.2. Heart Disease
      • 5.3.3. Global Amlodipine Besylater by: Ingredients (Volume)
        • 5.3.3.1. Microcrystalline Cellulose
        • 5.3.3.2. Dibasic Calcium Phosphate Anhydrous
        • 5.3.3.3. Sodium Starch Glycolate
        • 5.3.3.4. Others
      • 5.3.4. Global Amlodipine Besylater Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Amlodipine Besylater (Price)
      • 5.4.1. Global Amlodipine Besylater by: Type (Price)
  • 6. Amlodipine Besylater: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Mylan N.V. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Dr. Reddy's Laboratories (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Apotex Inc. (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cipla Limited (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hikma Pharmaceuticals (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Strides Pharma Science Limited (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Upsher-Smith Laboratories, LLC (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sun Pharmaceutical Industries Limited (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Amlodipine Besylater Sale, by Type, Application, Distribution Channel , Ingredients and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Amlodipine Besylater (Value)
      • 7.2.1. Global Amlodipine Besylater by: Type (Value)
        • 7.2.1.1. 2.5mg
        • 7.2.1.2. 5mg
        • 7.2.1.3. 10mg
      • 7.2.2. Global Amlodipine Besylater by: Application (Value)
        • 7.2.2.1. High Blood Pressure
        • 7.2.2.2. Heart Disease
      • 7.2.3. Global Amlodipine Besylater by: Ingredients (Value)
        • 7.2.3.1. Microcrystalline Cellulose
        • 7.2.3.2. Dibasic Calcium Phosphate Anhydrous
        • 7.2.3.3. Sodium Starch Glycolate
        • 7.2.3.4. Others
      • 7.2.4. Global Amlodipine Besylater Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Amlodipine Besylater (Volume)
      • 7.3.1. Global Amlodipine Besylater by: Type (Volume)
        • 7.3.1.1. 2.5mg
        • 7.3.1.2. 5mg
        • 7.3.1.3. 10mg
      • 7.3.2. Global Amlodipine Besylater by: Application (Volume)
        • 7.3.2.1. High Blood Pressure
        • 7.3.2.2. Heart Disease
      • 7.3.3. Global Amlodipine Besylater by: Ingredients (Volume)
        • 7.3.3.1. Microcrystalline Cellulose
        • 7.3.3.2. Dibasic Calcium Phosphate Anhydrous
        • 7.3.3.3. Sodium Starch Glycolate
        • 7.3.3.4. Others
      • 7.3.4. Global Amlodipine Besylater Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Amlodipine Besylater (Price)
      • 7.4.1. Global Amlodipine Besylater by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Amlodipine Besylater: by Type(USD Million)
  • Table 2. Amlodipine Besylater 2.5mg , by Region USD Million (2017-2022)
  • Table 3. Amlodipine Besylater 5mg , by Region USD Million (2017-2022)
  • Table 4. Amlodipine Besylater 10mg , by Region USD Million (2017-2022)
  • Table 5. Amlodipine Besylater: by Application(USD Million)
  • Table 6. Amlodipine Besylater High Blood Pressure , by Region USD Million (2017-2022)
  • Table 7. Amlodipine Besylater Heart Disease , by Region USD Million (2017-2022)
  • Table 8. Amlodipine Besylater: by Ingredients(USD Million)
  • Table 9. Amlodipine Besylater Microcrystalline Cellulose , by Region USD Million (2017-2022)
  • Table 10. Amlodipine Besylater Dibasic Calcium Phosphate Anhydrous , by Region USD Million (2017-2022)
  • Table 11. Amlodipine Besylater Sodium Starch Glycolate , by Region USD Million (2017-2022)
  • Table 12. Amlodipine Besylater Others , by Region USD Million (2017-2022)
  • Table 13. South America Amlodipine Besylater, by Country USD Million (2017-2022)
  • Table 14. South America Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 15. South America Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 16. South America Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 17. South America Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 18. Brazil Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 19. Brazil Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 20. Brazil Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 21. Brazil Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 22. Argentina Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 23. Argentina Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 24. Argentina Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 25. Argentina Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 26. Rest of South America Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 28. Rest of South America Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 29. Rest of South America Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 30. Asia Pacific Amlodipine Besylater, by Country USD Million (2017-2022)
  • Table 31. Asia Pacific Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 32. Asia Pacific Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 33. Asia Pacific Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 34. Asia Pacific Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 35. China Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 36. China Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 37. China Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 38. China Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 39. Japan Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 40. Japan Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 41. Japan Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 42. Japan Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 43. India Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 44. India Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 45. India Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 46. India Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 47. South Korea Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 48. South Korea Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 49. South Korea Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 50. South Korea Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 51. Taiwan Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 52. Taiwan Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 53. Taiwan Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 54. Taiwan Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 55. Australia Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 56. Australia Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 57. Australia Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 58. Australia Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 59. Rest of Asia-Pacific Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 60. Rest of Asia-Pacific Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 61. Rest of Asia-Pacific Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 63. Europe Amlodipine Besylater, by Country USD Million (2017-2022)
  • Table 64. Europe Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 65. Europe Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 66. Europe Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 67. Europe Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 68. Germany Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 69. Germany Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 70. Germany Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 71. Germany Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 72. France Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 73. France Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 74. France Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 75. France Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 76. Italy Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 77. Italy Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 78. Italy Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 79. Italy Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 80. United Kingdom Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 81. United Kingdom Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 82. United Kingdom Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 83. United Kingdom Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 84. Netherlands Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 85. Netherlands Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 86. Netherlands Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 87. Netherlands Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 88. Rest of Europe Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 89. Rest of Europe Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 90. Rest of Europe Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 91. Rest of Europe Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 92. MEA Amlodipine Besylater, by Country USD Million (2017-2022)
  • Table 93. MEA Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 94. MEA Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 95. MEA Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 96. MEA Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 97. Middle East Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 98. Middle East Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 99. Middle East Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 100. Middle East Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 101. Africa Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 102. Africa Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 103. Africa Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 104. Africa Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 105. North America Amlodipine Besylater, by Country USD Million (2017-2022)
  • Table 106. North America Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 107. North America Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 108. North America Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 109. North America Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 110. United States Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 111. United States Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 112. United States Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 113. United States Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 114. Canada Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 115. Canada Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 116. Canada Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 117. Canada Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 118. Mexico Amlodipine Besylater, by Type USD Million (2017-2022)
  • Table 119. Mexico Amlodipine Besylater, by Application USD Million (2017-2022)
  • Table 120. Mexico Amlodipine Besylater, by Distribution Channel USD Million (2017-2022)
  • Table 121. Mexico Amlodipine Besylater, by Ingredients USD Million (2017-2022)
  • Table 122. Amlodipine Besylater Sales: by Type(M Tons)
  • Table 123. Amlodipine Besylater Sales 2.5mg , by Region M Tons (2017-2022)
  • Table 124. Amlodipine Besylater Sales 5mg , by Region M Tons (2017-2022)
  • Table 125. Amlodipine Besylater Sales 10mg , by Region M Tons (2017-2022)
  • Table 126. Amlodipine Besylater Sales: by Application(M Tons)
  • Table 127. Amlodipine Besylater Sales High Blood Pressure , by Region M Tons (2017-2022)
  • Table 128. Amlodipine Besylater Sales Heart Disease , by Region M Tons (2017-2022)
  • Table 129. Amlodipine Besylater Sales: by Ingredients(M Tons)
  • Table 130. Amlodipine Besylater Sales Microcrystalline Cellulose , by Region M Tons (2017-2022)
  • Table 131. Amlodipine Besylater Sales Dibasic Calcium Phosphate Anhydrous , by Region M Tons (2017-2022)
  • Table 132. Amlodipine Besylater Sales Sodium Starch Glycolate , by Region M Tons (2017-2022)
  • Table 133. Amlodipine Besylater Sales Others , by Region M Tons (2017-2022)
  • Table 134. South America Amlodipine Besylater Sales, by Country M Tons (2017-2022)
  • Table 135. South America Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 136. South America Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 137. South America Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 138. South America Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 139. Brazil Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 140. Brazil Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 141. Brazil Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 142. Brazil Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 143. Argentina Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 144. Argentina Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 145. Argentina Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 146. Argentina Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 147. Rest of South America Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 148. Rest of South America Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 149. Rest of South America Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 150. Rest of South America Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 151. Asia Pacific Amlodipine Besylater Sales, by Country M Tons (2017-2022)
  • Table 152. Asia Pacific Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 153. Asia Pacific Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 154. Asia Pacific Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 155. Asia Pacific Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 156. China Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 157. China Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 158. China Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 159. China Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 160. Japan Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 161. Japan Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 162. Japan Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 163. Japan Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 164. India Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 165. India Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 166. India Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 167. India Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 168. South Korea Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 169. South Korea Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 170. South Korea Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 171. South Korea Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 172. Taiwan Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 173. Taiwan Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 174. Taiwan Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 175. Taiwan Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 176. Australia Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 177. Australia Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 178. Australia Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 179. Australia Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 180. Rest of Asia-Pacific Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 181. Rest of Asia-Pacific Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 182. Rest of Asia-Pacific Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 183. Rest of Asia-Pacific Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 184. Europe Amlodipine Besylater Sales, by Country M Tons (2017-2022)
  • Table 185. Europe Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 186. Europe Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 187. Europe Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 188. Europe Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 189. Germany Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 190. Germany Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 191. Germany Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 192. Germany Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 193. France Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 194. France Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 195. France Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 196. France Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 197. Italy Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 198. Italy Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 199. Italy Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 200. Italy Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 201. United Kingdom Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 202. United Kingdom Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 203. United Kingdom Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 204. United Kingdom Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 205. Netherlands Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 206. Netherlands Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 207. Netherlands Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 208. Netherlands Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 209. Rest of Europe Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 210. Rest of Europe Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 211. Rest of Europe Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 212. Rest of Europe Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 213. MEA Amlodipine Besylater Sales, by Country M Tons (2017-2022)
  • Table 214. MEA Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 215. MEA Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 216. MEA Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 217. MEA Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 218. Middle East Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 219. Middle East Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 220. Middle East Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 221. Middle East Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 222. Africa Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 223. Africa Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 224. Africa Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 225. Africa Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 226. North America Amlodipine Besylater Sales, by Country M Tons (2017-2022)
  • Table 227. North America Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 228. North America Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 229. North America Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 230. North America Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 231. United States Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 232. United States Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 233. United States Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 234. United States Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 235. Canada Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 236. Canada Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 237. Canada Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 238. Canada Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 239. Mexico Amlodipine Besylater Sales, by Type M Tons (2017-2022)
  • Table 240. Mexico Amlodipine Besylater Sales, by Application M Tons (2017-2022)
  • Table 241. Mexico Amlodipine Besylater Sales, by Distribution Channel M Tons (2017-2022)
  • Table 242. Mexico Amlodipine Besylater Sales, by Ingredients M Tons (2017-2022)
  • Table 243. Amlodipine Besylater: by Type(USD/Units)
  • Table 244. Company Basic Information, Sales Area and Its Competitors
  • Table 245. Company Basic Information, Sales Area and Its Competitors
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Amlodipine Besylater: by Type(USD Million)
  • Table 255. Amlodipine Besylater 2.5mg , by Region USD Million (2023-2028)
  • Table 256. Amlodipine Besylater 5mg , by Region USD Million (2023-2028)
  • Table 257. Amlodipine Besylater 10mg , by Region USD Million (2023-2028)
  • Table 258. Amlodipine Besylater: by Application(USD Million)
  • Table 259. Amlodipine Besylater High Blood Pressure , by Region USD Million (2023-2028)
  • Table 260. Amlodipine Besylater Heart Disease , by Region USD Million (2023-2028)
  • Table 261. Amlodipine Besylater: by Ingredients(USD Million)
  • Table 262. Amlodipine Besylater Microcrystalline Cellulose , by Region USD Million (2023-2028)
  • Table 263. Amlodipine Besylater Dibasic Calcium Phosphate Anhydrous , by Region USD Million (2023-2028)
  • Table 264. Amlodipine Besylater Sodium Starch Glycolate , by Region USD Million (2023-2028)
  • Table 265. Amlodipine Besylater Others , by Region USD Million (2023-2028)
  • Table 266. South America Amlodipine Besylater, by Country USD Million (2023-2028)
  • Table 267. South America Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 268. South America Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 269. South America Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 270. South America Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 271. Brazil Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 272. Brazil Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 273. Brazil Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 274. Brazil Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 275. Argentina Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 276. Argentina Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 277. Argentina Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 278. Argentina Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 279. Rest of South America Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 280. Rest of South America Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 281. Rest of South America Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 282. Rest of South America Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 283. Asia Pacific Amlodipine Besylater, by Country USD Million (2023-2028)
  • Table 284. Asia Pacific Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 285. Asia Pacific Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 286. Asia Pacific Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 287. Asia Pacific Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 288. China Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 289. China Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 290. China Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 291. China Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 292. Japan Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 293. Japan Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 294. Japan Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 295. Japan Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 296. India Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 297. India Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 298. India Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 299. India Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 300. South Korea Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 301. South Korea Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 302. South Korea Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 303. South Korea Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 304. Taiwan Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 305. Taiwan Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 306. Taiwan Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 307. Taiwan Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 308. Australia Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 309. Australia Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 310. Australia Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 311. Australia Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 312. Rest of Asia-Pacific Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 313. Rest of Asia-Pacific Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 314. Rest of Asia-Pacific Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 315. Rest of Asia-Pacific Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 316. Europe Amlodipine Besylater, by Country USD Million (2023-2028)
  • Table 317. Europe Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 318. Europe Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 319. Europe Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 320. Europe Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 321. Germany Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 322. Germany Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 323. Germany Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 324. Germany Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 325. France Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 326. France Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 327. France Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 328. France Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 329. Italy Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 330. Italy Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 331. Italy Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 332. Italy Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 333. United Kingdom Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 334. United Kingdom Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 335. United Kingdom Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 336. United Kingdom Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 337. Netherlands Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 338. Netherlands Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 339. Netherlands Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 340. Netherlands Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 341. Rest of Europe Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 342. Rest of Europe Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 343. Rest of Europe Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 344. Rest of Europe Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 345. MEA Amlodipine Besylater, by Country USD Million (2023-2028)
  • Table 346. MEA Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 347. MEA Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 348. MEA Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 349. MEA Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 350. Middle East Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 351. Middle East Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 352. Middle East Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 353. Middle East Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 354. Africa Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 355. Africa Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 356. Africa Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 357. Africa Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 358. North America Amlodipine Besylater, by Country USD Million (2023-2028)
  • Table 359. North America Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 360. North America Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 361. North America Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 362. North America Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 363. United States Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 364. United States Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 365. United States Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 366. United States Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 367. Canada Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 368. Canada Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 369. Canada Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 370. Canada Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 371. Mexico Amlodipine Besylater, by Type USD Million (2023-2028)
  • Table 372. Mexico Amlodipine Besylater, by Application USD Million (2023-2028)
  • Table 373. Mexico Amlodipine Besylater, by Distribution Channel USD Million (2023-2028)
  • Table 374. Mexico Amlodipine Besylater, by Ingredients USD Million (2023-2028)
  • Table 375. Amlodipine Besylater Sales: by Type(M Tons)
  • Table 376. Amlodipine Besylater Sales 2.5mg , by Region M Tons (2023-2028)
  • Table 377. Amlodipine Besylater Sales 5mg , by Region M Tons (2023-2028)
  • Table 378. Amlodipine Besylater Sales 10mg , by Region M Tons (2023-2028)
  • Table 379. Amlodipine Besylater Sales: by Application(M Tons)
  • Table 380. Amlodipine Besylater Sales High Blood Pressure , by Region M Tons (2023-2028)
  • Table 381. Amlodipine Besylater Sales Heart Disease , by Region M Tons (2023-2028)
  • Table 382. Amlodipine Besylater Sales: by Ingredients(M Tons)
  • Table 383. Amlodipine Besylater Sales Microcrystalline Cellulose , by Region M Tons (2023-2028)
  • Table 384. Amlodipine Besylater Sales Dibasic Calcium Phosphate Anhydrous , by Region M Tons (2023-2028)
  • Table 385. Amlodipine Besylater Sales Sodium Starch Glycolate , by Region M Tons (2023-2028)
  • Table 386. Amlodipine Besylater Sales Others , by Region M Tons (2023-2028)
  • Table 387. South America Amlodipine Besylater Sales, by Country M Tons (2023-2028)
  • Table 388. South America Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 389. South America Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 390. South America Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 391. South America Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 392. Brazil Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 393. Brazil Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 394. Brazil Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 395. Brazil Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 396. Argentina Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 397. Argentina Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 398. Argentina Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 399. Argentina Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 400. Rest of South America Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 401. Rest of South America Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 402. Rest of South America Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 403. Rest of South America Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 404. Asia Pacific Amlodipine Besylater Sales, by Country M Tons (2023-2028)
  • Table 405. Asia Pacific Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 406. Asia Pacific Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 407. Asia Pacific Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 408. Asia Pacific Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 409. China Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 410. China Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 411. China Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 412. China Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 413. Japan Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 414. Japan Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 415. Japan Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 416. Japan Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 417. India Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 418. India Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 419. India Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 420. India Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 421. South Korea Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 422. South Korea Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 423. South Korea Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 424. South Korea Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 425. Taiwan Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 426. Taiwan Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 427. Taiwan Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 428. Taiwan Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 429. Australia Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 430. Australia Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 431. Australia Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 432. Australia Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 433. Rest of Asia-Pacific Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 434. Rest of Asia-Pacific Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 435. Rest of Asia-Pacific Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 436. Rest of Asia-Pacific Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 437. Europe Amlodipine Besylater Sales, by Country M Tons (2023-2028)
  • Table 438. Europe Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 439. Europe Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 440. Europe Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 441. Europe Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 442. Germany Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 443. Germany Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 444. Germany Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 445. Germany Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 446. France Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 447. France Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 448. France Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 449. France Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 450. Italy Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 451. Italy Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 452. Italy Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 453. Italy Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 454. United Kingdom Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 455. United Kingdom Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 456. United Kingdom Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 457. United Kingdom Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 458. Netherlands Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 459. Netherlands Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 460. Netherlands Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 461. Netherlands Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 462. Rest of Europe Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 463. Rest of Europe Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 464. Rest of Europe Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 465. Rest of Europe Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 466. MEA Amlodipine Besylater Sales, by Country M Tons (2023-2028)
  • Table 467. MEA Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 468. MEA Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 469. MEA Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 470. MEA Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 471. Middle East Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 472. Middle East Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 473. Middle East Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 474. Middle East Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 475. Africa Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 476. Africa Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 477. Africa Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 478. Africa Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 479. North America Amlodipine Besylater Sales, by Country M Tons (2023-2028)
  • Table 480. North America Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 481. North America Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 482. North America Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 483. North America Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 484. United States Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 485. United States Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 486. United States Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 487. United States Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 488. Canada Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 489. Canada Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 490. Canada Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 491. Canada Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 492. Mexico Amlodipine Besylater Sales, by Type M Tons (2023-2028)
  • Table 493. Mexico Amlodipine Besylater Sales, by Application M Tons (2023-2028)
  • Table 494. Mexico Amlodipine Besylater Sales, by Distribution Channel M Tons (2023-2028)
  • Table 495. Mexico Amlodipine Besylater Sales, by Ingredients M Tons (2023-2028)
  • Table 496. Amlodipine Besylater: by Type(USD/Units)
  • Table 497. Research Programs/Design for This Report
  • Table 498. Key Data Information from Secondary Sources
  • Table 499. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Amlodipine Besylater: by Type USD Million (2017-2022)
  • Figure 5. Global Amlodipine Besylater: by Application USD Million (2017-2022)
  • Figure 6. Global Amlodipine Besylater: by Ingredients USD Million (2017-2022)
  • Figure 7. South America Amlodipine Besylater Share (%), by Country
  • Figure 8. Asia Pacific Amlodipine Besylater Share (%), by Country
  • Figure 9. Europe Amlodipine Besylater Share (%), by Country
  • Figure 10. MEA Amlodipine Besylater Share (%), by Country
  • Figure 11. North America Amlodipine Besylater Share (%), by Country
  • Figure 12. Global Amlodipine Besylater: by Type M Tons (2017-2022)
  • Figure 13. Global Amlodipine Besylater: by Application M Tons (2017-2022)
  • Figure 14. Global Amlodipine Besylater: by Ingredients M Tons (2017-2022)
  • Figure 15. South America Amlodipine Besylater Share (%), by Country
  • Figure 16. Asia Pacific Amlodipine Besylater Share (%), by Country
  • Figure 17. Europe Amlodipine Besylater Share (%), by Country
  • Figure 18. MEA Amlodipine Besylater Share (%), by Country
  • Figure 19. North America Amlodipine Besylater Share (%), by Country
  • Figure 20. Global Amlodipine Besylater: by Type USD/Units (2017-2022)
  • Figure 21. Global Amlodipine Besylater share by Players 2022 (%)
  • Figure 22. Global Amlodipine Besylater share by Players (Top 3) 2022(%)
  • Figure 23. Global Amlodipine Besylater share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Mylan N.V. (United States) Revenue: by Geography 2022
  • Figure 29. Dr. Reddy's Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 30. Dr. Reddy's Laboratories (India) Revenue: by Geography 2022
  • Figure 31. Apotex Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 32. Apotex Inc. (Canada) Revenue: by Geography 2022
  • Figure 33. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 34. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2022
  • Figure 35. Cipla Limited (India) Revenue, Net Income and Gross profit
  • Figure 36. Cipla Limited (India) Revenue: by Geography 2022
  • Figure 37. Hikma Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 38. Hikma Pharmaceuticals (United Kingdom) Revenue: by Geography 2022
  • Figure 39. Strides Pharma Science Limited (India) Revenue, Net Income and Gross profit
  • Figure 40. Strides Pharma Science Limited (India) Revenue: by Geography 2022
  • Figure 41. Upsher-Smith Laboratories, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 42. Upsher-Smith Laboratories, LLC (United States) Revenue: by Geography 2022
  • Figure 43. Sun Pharmaceutical Industries Limited (India) Revenue, Net Income and Gross profit
  • Figure 44. Sun Pharmaceutical Industries Limited (India) Revenue: by Geography 2022
  • Figure 45. Global Amlodipine Besylater: by Type USD Million (2023-2028)
  • Figure 46. Global Amlodipine Besylater: by Application USD Million (2023-2028)
  • Figure 47. Global Amlodipine Besylater: by Ingredients USD Million (2023-2028)
  • Figure 48. South America Amlodipine Besylater Share (%), by Country
  • Figure 49. Asia Pacific Amlodipine Besylater Share (%), by Country
  • Figure 50. Europe Amlodipine Besylater Share (%), by Country
  • Figure 51. MEA Amlodipine Besylater Share (%), by Country
  • Figure 52. North America Amlodipine Besylater Share (%), by Country
  • Figure 53. Global Amlodipine Besylater: by Type M Tons (2023-2028)
  • Figure 54. Global Amlodipine Besylater: by Application M Tons (2023-2028)
  • Figure 55. Global Amlodipine Besylater: by Ingredients M Tons (2023-2028)
  • Figure 56. South America Amlodipine Besylater Share (%), by Country
  • Figure 57. Asia Pacific Amlodipine Besylater Share (%), by Country
  • Figure 58. Europe Amlodipine Besylater Share (%), by Country
  • Figure 59. MEA Amlodipine Besylater Share (%), by Country
  • Figure 60. North America Amlodipine Besylater Share (%), by Country
  • Figure 61. Global Amlodipine Besylater: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Pfizer Inc. (United States)
  • Mylan N.V. (United States)
  • Dr. Reddy's Laboratories (India)
  • Apotex Inc. (Canada)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Cipla Limited (India)
  • Hikma Pharmaceuticals (United Kingdom)
  • Strides Pharma Science Limited (India)
  • Upsher-Smith Laboratories, LLC (United States)
  • Sun Pharmaceutical Industries Limited (India)
Additional players considered in the study are as follows:
Aurobindo Pharma Limited (India) , Lupin Pharmaceuticals (India) , Zydus Pharmaceuticals (United States) , Oxford PharmaGenesis Ltd. (United Kingdom) , Wockhardt Ltd (India) , Epic Pharma, LLC (United States)
Select User Access Type

Key Highlights of Report


Jun 2023 232 Pages 87 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Amlodipine Besylater Market Quantitative research analysis
Global Amlodipine Besylater Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

"Change of lifestyle and Growing Aging of the Population " is seen as one of major growth factors of Amlodipine Besylater Market in years to come.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
The Amlodipine Besylater market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Amlodipine Besylater Market Report?

Have a Query? Click Here

Other Related Reports

Mouth Ulcers Drugs Comprehensive Study by Type (Corticosteroid , Anesthetic , Analgesic , Antihistamine , Antimicrobial), Application (Adults, Kids), Indication Type (Aphthous Stomatitis, Oral Lichen...
$ 3650
Sterile Medical Packaging Comprehensive Study by Type (Thermoform trays, Sterile bottles & containers, Vials & ampoules, Pre-fillable inhalers, Sterile closures, Pre-filled syringes, Blister & clamsh...
$ 3750
Specialty Pharmaceutical Comprehensive Study by Application (Hospitals, Specialty Pharmacies, Others (Mail Order)), Route of administration (Oral, Parenteral, Transdermal), Therapeutic area (Oncolo...
$ 3650
Anticoagulant Drug Comprehensive Study by Type (Coumarins & Indandiones, Factor Xa Inhibitors, Heparins, Thrombin Inhibitors), Application (Atrial Fibrillation, Deep Vein Thrombosis, Artificial Heart...
$ 3750
Neurological Disorder Drugs Comprehensive Study by Type (Antipsychotic, Antiepileptic, Anticholinergic, Analgesics, Hypnotic and Sedative, Antihypertensive, Anticoagulants, Others), Application (Hosp...
$ 3750
Glycopyrrolate Comprehensive Study by Application (Hospitals, Clinics), Form (Tablet, Solution), Sales Channel (Offline (Pharma Stores, Medical Outlets), Online (E-commerce)) Players and Region - Glo...
$ 3500